Immunocore Holdings (STU:6YG) Cash From Discontinued Investing Activities : €0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Immunocore Holdings's cash from discontinued investing activities for the three months ended in Mar. 2025 was €0.0 Mil. It means Immunocore Holdings received €0.0 Mil from discontinued investing activities. Immunocore Holdings's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Mar. 2025 was €0.0 Mil.

Immunocore Holdings Cash From Discontinued Investing Activities Historical Data

The historical data trend for Immunocore Holdings's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Cash From Discontinued Investing Activities Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash From Discontinued Investing Activities

Get a 7-Day Free Trial

Immunocore Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash From Discontinued Investing Activities	Get a 7-Day Free Trial															-	-	-	-	-

Immunocore Holdings Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Immunocore Holdings Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (STU:6YG) » Definitions » Cash From Discontinued Investing Activities

Comparable Companies

Traded in Other Exchanges

IMCR:USA

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Immunocore Holdings Headlines

No Headlines